v3.26.3
Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Segment Reporting [Line Items]          
Rental revenues (including tenant reimbursements) $ 64,743,000 $ 64,292,000 $ 196,553,000 $ 198,855,000  
Other revenues 177,000 393,000 678,000 443,000  
Total revenues 64,920,000 64,685,000 197,231,000 199,298,000  
Property expenses 6,939,000 7,951,000 21,711,000 22,197,000  
Depreciation and amortization expense 19,572,000 18,639,000 56,955,000 55,530,000  
Impairment loss on real estate 567,000 0 567,000 3,527,000  
Gain (loss) on sale of real estate, net 0 0 12,269,000 0  
Interest and other income 14,331,000 4,416,000 31,414,000 7,599,000  
Interest expense (11,820,000) (4,525,000) (26,599,000) (13,469,000)  
Net income 31,895,000 29,305,000 108,556,000 86,406,000  
General and administrative expense 8,458,000 8,681,000 26,526,000 25,768,000  
Preferred stock dividends (3,187,000) (1,017,000) (9,028,000) (2,676,000)  
Net income attributable to common stockholders 28,708,000 28,288,000 99,528,000 83,730,000  
Segment Total Assets 2,650,715,000   2,650,715,000   $ 2,370,858,000
Operating Segments          
Segment Reporting [Line Items]          
Net income 50,810,000 41,770,000 159,121,000 123,089,000  
Operating Segments | Cannabis Portfolio Segment          
Segment Reporting [Line Items]          
Rental revenues (including tenant reimbursements) 64,743,000 64,292,000 196,553,000 198,855,000  
Other revenues 177,000 393,000 678,000 443,000  
Total revenues 64,920,000 64,685,000 197,231,000 199,298,000  
Property expenses 6,939,000 7,951,000 21,711,000 22,197,000  
Depreciation and amortization expense 19,572,000 18,639,000 56,955,000 55,530,000  
Impairment loss on real estate 567,000 0 567,000 3,527,000  
Gain (loss) on sale of real estate, net 0 0 12,269,000 0  
Interest and other income 2,595,000 3,675,000 4,466,000 5,045,000  
Net income 40,437,000 41,770,000 134,733,000 123,089,000  
Segment Total Assets 2,085,136,000   2,085,136,000   2,165,359,000
Operating Segments | Life Science Portfolio Segment          
Segment Reporting [Line Items]          
Interest and other income 10,373,000 0 24,388,000 0  
Net income 10,373,000 0 24,388,000 0  
Segment Total Assets 417,416,000   417,416,000   152,665,000
Unallocated:          
Segment Reporting [Line Items]          
Interest and other income 1,363,000 741,000 2,560,000 2,554,000  
Interest expense (11,820,000) (4,525,000) (26,599,000) (13,469,000)  
Net income 31,895,000 29,305,000 108,556,000 86,406,000  
General and administrative expense 8,458,000 $ 8,681,000 26,526,000 $ 25,768,000  
Segment Total Assets $ 148,163,000   $ 148,163,000   $ 52,834,000